RecruitingNCT06491602
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
Sponsor
Sohag University
Enrollment
30 participants
Start Date
Jun 24, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
systemic lupus erthrematosus is an inflamatory and autoimmune condition characterized by multisystem affection and chronic course with unpredictable flares despite potentially afffecting every oragan . kidney involvment are the most common
Eligibility
Min Age: 1 MonthMax Age: 18 Years
Inclusion Criteria1
- \- aim to include all children fulfilling diagnostic criteria
Exclusion Criteria1
- children with other rheumatological disorder neonates chidren with other nephrolgy disorder
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTrenal biobsy
analsis of renal biobsy and decide grade of renal affection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06491602
Related Trials
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
NCT0503961942 locations
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT0630897818 locations
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis
NCT0705380026 locations
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
NCT0701598393 locations
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
NCT05268289103 locations